Acceptance Tests and Quality Control of the Positron Emission Tomography (PET) Systems

Guideline

Acceptance Tests and Quality Control of the Positron Emission Tomography (PET) Systems

Nucl Med Semin 2020;6(2):51-70 DOI: 10.4274/nts.galenos.2020.0008
, , , , , ,
Permissions

Abstract

Quality control (QC) applications are important for the reliability and accuracy of the results obtained from positron emission tomography (PET) imaging systems in clinical trials. With these applications, exposure of patients and employees to more radiation will be prevented, and it will be possible to detect the systems that lost their performance compared to their installation time. QC applications are grouped as acceptance and reference tests, routine periodic QC tests. PET performance tests standardized by National Electrical Manufacturers Association (NEMA) should be used as acceptance and reference tests. In addition, the performance of the device should be monitored by following these tests at six-month intervals. PET/computerized tomography (CT) manufacturers often recommend routine QC procedures for their equipment and require users to follow these recommendations to a minimum. If standards are not defined for routine QC procedures, it is recommended to comply with the general minimum standards for routine QC that all PET/CT centers must perform. Routine QC protocols, the image quality of the PET system; CT image quality and CT dose of the patient; the accuracy of CT-based attenuation corrections; the accuracy of the CT and PET co-registration should ensure that problems that can interact any of the performance characteristics are identified. Since performing PET/CT scans by equipment that does not comply with their specifications may compromise image quality, interpretation of images and reliability of results, daily QC parameters must be evaluated and necessary corrective procedures must be taken prior to scanning. The tests are carried out using the protocol provided by the manufacturer.

Keywords: PET equipment, PET/CT, acceptance and quality control tests

References

1

National Electrical Manufacturers Association (NEMA), Standards Publication NU 2-2012, Performance Measurements of Positron Emission Tomographs. 2012, Rosslyn, VA.

2

Turkington TG. Introduction to PET instrumentation. J Nucl Med Technol 2001;29:4-11.

3

Rausch I, Ruiz A, Valverde-Pascual I, Cal-González J, Beyer T, Carrio I. Performance Evaluation of the Vereos PET/CT System According to the NEMA NU2-2012 Standard. J Nucl Med 2019;60:561-567.

4

Demir M, Toklu T, Abuqbeitah M, et al. Evaluation of PET Scanner Performance in PET/MR and PET/CT Systems: NEMA Tests. Mol Imaging Radionucl Ther 2018;27:10-18.

5

Jones T, Townsend D. History and future technical innovation in positron emission tomography. J Med Imaging 2017;4:011013.

6

Serrano PE, Gu CS, Moulton CA, et al. Effect of PET-CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long-term results of a randomized controlled trial. J Surg Oncol 2020;121:1001-1006.

7

Oldan JD, Khandani AH, Fielding JR, et al. Quantitative accuracy of positron emission tomography/magnetic resonance and positron emission tomography/computed tomography for cervical cancer. World J Nucl Med 2018;17:213-218.

8

Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41:1369-1379.

9

Glaudemans AW, de Vries EF, Galli F, Dierckx RA, Slart RH, Signore A. The use of F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases. Clin Dev Immunol 2013;2013:623036.

10

Jian QY, Doss M, Codreanu I, Zhuang H. PET/CT in patients with sarcoidosis or IgG4 diseae. PET Clin 2012;7:191-210.

11

Schwaiger M, Ziegler S, Nekolla SG. PET/CT: Challenge for nuclear cardiology. J Nucl Med 2005;46:1664-1678.

12

Berti V, Pupi A, Mosconi L. PET/CT in diagnosis of dementia. Ann N Y Acad Sci 2011;1228:81-92.

13

Ehman EC, Johnson GB, Villanueva-Meyer JE, et al. PET/MRI: Where Might It Replace PET/CT? Magn Reson Imaging 2017;46:1247-1262.

14

Herrmann KA, Kohan AA, Gaeta MC, et al. PET/MRI: applications in clinical imaging. Curr Radiol Rep 2013;1:161-176.

15

Torigian DA, Zaidi H, Kwee TC, et al. PET/MR imaging: technical aspects and potential clinical applications. Radiology 2013;267:26-44.

16

National Electrical Manufacturers Association (NEMA), Standards Publication NU 2-2007, Performance Measurements of Positron Emission Tomographs. 2007, Rosslyn, VA.

17

IAEA Human Health Series No.1 Quality Assurance for PET and PET/CT Systems. VIENNA, 2009.

18

Değer M, Demir M, İnce M, ve ark. Kalite Kontrol, Enstrümantasyon ve Radyasyon Güvenliği Komitesi Yönergesi. Bölüm II PET sistemlerinin kalite kontrolü ve kabul testleri. Turk J Nucl Med 2004;13:118-139.

19

Witherspoon ME, Karp JS, Casey ME, et al. PET performance measurement using the NEMA NU 2-2001 Standard. J Nucl Med 2002;43:1398-1409.

20

National Electrical Manufacturers Association. NEMA Standards Publication NU 2-2001: Performance Measurements of Positron Emission Tomographs 2001, Rosslyn, VA.

21

National Electrical Manufacturers Association. NEMA Standards Publication NU 2-1994: Performance Measurements of Positron Emission Tomographs. 1994, Washington, DC.

22

Clementel E, Vandenberghe S, Karp JS, Surti S. Evaluation of image signal-to noise ratio in time-of-flight PET. 2011 IEEE Nucl Sci Symp Conf Rec 2011;3917-3921.

23

Antic V, Haglund J. Connections between noise equivalent count rate and image noise in PET medical imaging. RAD Conf Proc 2016;1:187-190.